ACAD
Acadia Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
Latest data update time: Updated on 2026-01-31
5.11 / 10Overall Score
NeturalInvestment Rating
5.11 / 10Overall Score
NeturalInvestment Rating
Is ACAD a Buy, Sell, or Hold?
- Based on a composite score of 5.11/10, we rate ACAD as a Netural. Our analysis breaks down into 5.05/10 for Fundamentals, 4.44/10 for Technicals, and 5.46/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Technical Analysis of ACAD?
Is ACAD undervalued or overvalued?
What is the analyst consensus for ACAD?
Is ACAD a Buy, Sell, or Hold?
- Based on a composite score of 5.11/10, we rate ACAD as a Netural. Our analysis breaks down into 5.05/10 for Fundamentals, 4.44/10 for Technicals, and 5.46/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is ACAD undervalued or overvalued?
Technical Analysis of ACAD?
What is the analyst consensus for ACAD?
